Table 2.
Demographic and clinical data of PD patients at different stage.
| Mild (n = 17) | Moderate/severe (n = 17) | p value | |
|---|---|---|---|
| Age | 57.72 ± 9.51 | 61.13 ± 7.53 | 0.256 |
| Gender (F/M) | 7/10 | 7/10 | 1.000 |
| Education | 8.35 ± 5.35 | 7.00 ± 4.37 | 0.425 |
| Duration | 1.72 ± 1.40 | 3.06 ± 2.14 | 0.039* |
| TIV | 1508.90 ± 150.45 | 1459.51 ± 152.23 | 0.349 |
| LEDD | 147.06 ± 145.47 | 320.59 ± 313.53 | 0.050* |
| UPDRS total | 18.29 ± 16.71 | 35.47 ± 12.89 | 0.002** |
| UPDRS part I | 0.82 ± 1.13 | 1.59 ± 1.62 | 0.121 |
| UPDRS part II | 4.41 ± 4.11 | 8.71 ± 4.28 | 0.005** |
| UPDRS part III | 12.82 ± 12.67 | 24.53 ± 8.71 | 0.004** |
| UPDRS part IV | 0.24 ± 0.44 | 0.65 ± 0.93 | 0.113 |
| MMSE | 28.00 ± 2.18 | 26.88 ± 4.56 | 0.368 |
| MoCA | 22.41 ± 5.20 | 22.06 ± 5.27 | 0.845 |
| HAMD | 5.00 ± 3.89 | 4.71 ± 3.97 | 0.829 |
| HAMA | 4.35 ± 2.78 | 5.24 ± 5.57 | 0.563 |
| PDQ-39 | 13.00 ± 7.37 | 28.59 ± 24.61 | 0.022* |
*p < 0.05. **p < 0.01.